Are we moving toward ending SARS-CoV-2?
J Med Virol
.
2022 Jul;94(7):2921-2924.
doi: 10.1002/jmv.27722.
Epub 2022 Mar 23.
Authors
Anurag R Mishra
1
,
Debasis Nayak
2
,
Siddappa N Byrareddy
3
4
5
6
Affiliations
1
Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, Madhya Pradesh, India.
2
Department of Biological Sciences, Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh, India.
3
Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA.
4
Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
5
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
6
Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
PMID:
35288953
PMCID:
PMC9088646
DOI:
10.1002/jmv.27722
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19* / prevention & control
Humans
SARS-CoV-2*
Grants and funding
R01 AI113883/AI/NIAID NIH HHS/United States
R01 AI129745/AI/NIAID NIH HHS/United States
R01 DA052845/DA/NIDA NIH HHS/United States